Cencora Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order … Read more
Cencora Inc. (COR) - Net Assets
Latest net assets as of December 2025: $2.10 Billion USD
Based on the latest financial reports, Cencora Inc. (COR) has net assets worth $2.10 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($78.36 Billion) and total liabilities ($76.27 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.10 Billion |
| % of Total Assets | 2.67% |
| Annual Growth Rate | N/A |
| 5-Year Change | 158.04% |
| 10-Year Change | -29.18% |
| Growth Volatility | 222.63 |
Cencora Inc. - Net Assets Trend (1994–2025)
This chart illustrates how Cencora Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cencora Inc. (1994–2025)
The table below shows the annual net assets of Cencora Inc. from 1994 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $1.51 Billion | +133.46% |
| 2024-09-30 | $645.94 Million | +23.74% |
| 2023-09-30 | $522.00 Million | +632.40% |
| 2022-09-30 | $71.27 Million | -87.80% |
| 2021-09-30 | $584.41 Million | +157.36% |
| 2020-09-30 | $-1.02 Billion | -134.04% |
| 2019-09-30 | $2.99 Billion | -1.86% |
| 2018-09-30 | $3.05 Billion | +44.24% |
| 2017-09-30 | $2.11 Billion | -0.70% |
| 2016-09-30 | $2.13 Billion | +236.12% |
| 2015-09-30 | $633.52 Million | -67.63% |
| 2014-09-30 | $1.96 Billion | -15.64% |
| 2013-09-30 | $2.32 Billion | -5.58% |
| 2012-09-30 | $2.46 Billion | -14.31% |
| 2011-09-30 | $2.87 Billion | -2.96% |
| 2010-09-30 | $2.95 Billion | +8.76% |
| 2009-09-30 | $2.72 Billion | +0.24% |
| 2008-09-30 | $2.71 Billion | -12.57% |
| 2007-09-30 | $3.10 Billion | -25.15% |
| 2006-09-30 | $4.14 Billion | -3.25% |
| 2005-09-30 | $4.28 Billion | -1.35% |
| 2004-09-30 | $4.34 Billion | +8.33% |
| 2003-09-30 | $4.01 Billion | +20.78% |
| 2002-09-30 | $3.32 Billion | +16.83% |
| 2001-09-30 | $2.84 Billion | +905.53% |
| 2000-09-30 | $282.29 Million | +69.75% |
| 1999-09-30 | $166.30 Million | +120.85% |
| 1998-09-30 | $75.30 Million | +426.57% |
| 1997-09-30 | $14.30 Million | +138.86% |
| 1996-09-30 | $-36.80 Million | +72.88% |
| 1995-09-30 | $-135.70 Million | +54.87% |
| 1994-09-30 | $-300.70 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cencora Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 683922700000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $6.53 Billion | 433.30% |
| Common Stock | $2.97 Million | 0.20% |
| Other Comprehensive Income | $-901.38 Million | -59.77% |
| Total Equity | $1.51 Billion | 100.00% |
Cencora Inc. Competitors by Market Cap
The table below lists competitors of Cencora Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tokio Marine Holdings Inc
PINK:TKOMY
|
$62.70 Billion |
|
Sempra
LSE:0L5A
|
$62.72 Billion |
|
TC Energy Corp
NYSE:TRP
|
$62.83 Billion |
|
DoorDash, Inc. Class A Common Stock
NASDAQ:DASH
|
$63.10 Billion |
|
Air Products and Chemicals Inc
NYSE:APD
|
$62.29 Billion |
|
Valero Energy Corporation
NYSE:VLO
|
$62.18 Billion |
|
Wheaton Precious Metals Corp
NYSE:WPM
|
$62.18 Billion |
|
ENEL Societa per Azioni
PINK:ENLAY
|
$61.90 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cencora Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 645,938,000 to 1,508,019,000, a change of 862,081,000 (133.5%).
- Net income of 1,554,169,000 contributed positively to equity growth.
- Dividend payments of 437,081,000 reduced retained earnings.
- Share repurchases of 435,471,000 reduced equity.
- Other comprehensive income increased equity by 87,740,000.
- Other factors increased equity by 92,724,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.55 Billion | +103.06% |
| Dividends Paid | $437.08 Million | -28.98% |
| Share Repurchases | $435.47 Million | -28.88% |
| Other Comprehensive Income | $87.74 Million | +5.82% |
| Other Changes | $92.72 Million | +6.15% |
| Total Change | $- | 133.46% |
Book Value vs Market Value Analysis
This analysis compares Cencora Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 43.33x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1994-09-30 | $-2.58 | $334.71 | x |
| 1995-09-30 | $-0.93 | $334.71 | x |
| 1996-09-30 | $-0.20 | $334.71 | x |
| 1997-09-30 | $0.07 | $334.71 | x |
| 1998-09-30 | $0.37 | $334.71 | x |
| 1999-09-30 | $0.80 | $334.71 | x |
| 2000-09-30 | $1.36 | $334.71 | x |
| 2001-09-30 | $11.30 | $334.71 | x |
| 2002-09-30 | $7.39 | $334.71 | x |
| 2003-09-30 | $8.64 | $334.71 | x |
| 2004-09-30 | $9.21 | $334.71 | x |
| 2005-09-30 | $9.93 | $334.71 | x |
| 2006-09-30 | $9.98 | $334.71 | x |
| 2007-09-30 | $8.25 | $334.71 | x |
| 2008-09-30 | $8.34 | $334.71 | x |
| 2009-09-30 | $8.97 | $334.71 | x |
| 2010-09-30 | $10.28 | $334.71 | x |
| 2011-09-30 | $10.32 | $334.71 | x |
| 2012-09-30 | $9.56 | $334.71 | x |
| 2013-09-30 | $9.86 | $334.71 | x |
| 2014-09-30 | $8.31 | $334.71 | x |
| 2015-09-30 | $2.91 | $334.71 | x |
| 2016-09-30 | $9.42 | $334.71 | x |
| 2017-09-30 | $9.54 | $334.71 | x |
| 2018-09-30 | $13.31 | $334.71 | x |
| 2019-09-30 | $14.13 | $334.71 | x |
| 2020-09-30 | $-4.10 | $334.71 | x |
| 2021-09-30 | $1.07 | $334.71 | x |
| 2022-09-30 | $-1.37 | $334.71 | x |
| 2023-09-30 | $2.55 | $334.71 | x |
| 2024-09-30 | $3.23 | $334.71 | x |
| 2025-09-30 | $7.72 | $334.71 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cencora Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 103.06%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.48%
- • Asset Turnover: 4.20x
- • Equity Multiplier: 50.79x
- Recent ROE (103.06%) is above the historical average (68.06%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1994 | 0.00% | -4.83% | 6.05x | 0.00x | $-177.63 Million |
| 1995 | 0.00% | 0.22% | 5.57x | 0.00x | $23.77 Million |
| 1996 | 0.00% | 0.64% | 4.67x | 0.00x | $39.18 Million |
| 1997 | 317.48% | 0.58% | 4.48x | 122.03x | $43.97 Million |
| 1998 | 67.07% | 0.58% | 5.58x | 20.61x | $42.97 Million |
| 1999 | 40.59% | 0.69% | 4.76x | 12.39x | $50.87 Million |
| 2000 | 35.07% | 0.85% | 4.74x | 8.71x | $70.78 Million |
| 2001 | 4.41% | 0.77% | 1.57x | 3.63x | $-158.75 Million |
| 2002 | 10.40% | 0.76% | 4.03x | 3.38x | $13.31 Million |
| 2003 | 11.02% | 0.89% | 4.12x | 3.01x | $40.70 Million |
| 2004 | 10.79% | 0.88% | 4.56x | 2.69x | $34.49 Million |
| 2005 | 7.46% | 0.58% | 4.80x | 2.66x | $-108.84 Million |
| 2006 | 11.29% | 0.76% | 4.79x | 3.09x | $53.60 Million |
| 2007 | 15.14% | 0.71% | 5.37x | 3.97x | $159.19 Million |
| 2008 | 9.25% | 0.36% | 5.74x | 4.51x | $-20.45 Million |
| 2009 | 18.53% | 0.70% | 5.29x | 5.00x | $231.75 Million |
| 2010 | 21.55% | 0.82% | 5.40x | 4.89x | $341.32 Million |
| 2011 | 24.65% | 0.88% | 5.35x | 5.23x | $419.94 Million |
| 2012 | 29.27% | 0.90% | 5.15x | 6.29x | $473.31 Million |
| 2013 | 18.70% | 0.49% | 4.65x | 8.16x | $201.73 Million |
| 2014 | 14.13% | 0.23% | 5.55x | 11.00x | $80.79 Million |
| 2015 | -21.29% | -0.10% | 4.90x | 43.78x | $-198.24 Million |
| 2016 | 67.06% | 0.97% | 4.37x | 15.77x | $1.21 Billion |
| 2017 | 19.60% | 0.27% | 4.34x | 16.70x | $203.04 Million |
| 2018 | 56.55% | 0.99% | 4.46x | 12.84x | $1.37 Billion |
| 2019 | 28.58% | 0.48% | 4.58x | 13.09x | $556.04 Million |
| 2020 | 0.00% | -1.79% | 4.29x | 0.00x | $-3.32 Billion |
| 2021 | 689.46% | 0.72% | 3.73x | 256.71x | $1.52 Billion |
| 2022 | 0.00% | 0.71% | 4.22x | 0.00x | $1.73 Billion |
| 2023 | 334.35% | 0.67% | 4.19x | 119.84x | $1.69 Billion |
| 2024 | 233.63% | 0.51% | 4.38x | 103.88x | $1.44 Billion |
| 2025 | 103.06% | 0.48% | 4.20x | 50.79x | $1.40 Billion |
Industry Comparison
This section compares Cencora Inc.'s net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $949,001,883
- Average return on equity (ROE) among peers: -5.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cencora Inc. (COR) | $2.10 Billion | 0.00% | 36.39x | $62.31 Billion |
| Accendra Health Inc (ACH) | $314.40 Million | 8.91% | 1.75x | $22.90K |
| Arjo AB (publ) (ARRJF) | $6.88 Billion | 10.78% | 1.12x | $491.29 Million |
| Cardinal Health Inc (CAH) | $255.60 Million | 13.15% | 1.57x | $50.81 Billion |
| Cosmos Health Inc. (COSM) | $36.04 Million | -51.45% | 0.83x | $8.90 Million |
| EDAP TMS SA (EDAP) | $50.05 Million | 1.40% | 0.54x | $115.72 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $741.21K | -42.90% | 4.10x | $9.16 Million |
| Energy Management International Inc (ENMI) | $-362.21K | 0.00% | 0.00x | $383.13K |
| Exlites Holdings International Inc (EXHI) | $-84.27 | 0.00% | 0.00x | $574.58K |
| Galenica AG (GALNF) | $999.54 Million | 12.50% | 1.21x | $3.75 Billion |